Alzheimer's and Dementia: Translational Research and Clinical Interventions
ESCI-ISI SCOPUS (2015-2025)
2352-8737
Mỹ
Cơ quản chủ quản: WILEY , John Wiley & Sons Inc.
Lĩnh vực:
Psychiatry and Mental HealthNeurology (clinical)
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Inflammation as a central mechanism in Alzheimer's disease
Tập 4 Số 1 - Trang 575-590 - 2018
AbstractAlzheimer's disease (AD) is a progressive neurodegenerative disorder
that is characterized by cognitive decline and the presence of two core
pathologies, amyloid β plaques and neurofibrillary tangles. Over the last
decade, the presence of a sustained immune response in the brain has emerged as
a third core pathology in AD. The sustained activation of the brain's resident
macrophages (micro...
Alzheimer's disease drug development pipeline: 2018
Tập 4 Số 1 - Trang 195-214 - 2018
AbstractIntroductionTreatments for Alzheimer's disease (AD) are needed due to
the growing number of individuals with preclinical, prodromal, and dementia
forms of AD. Drug development for AD therapies can be examined by inspecting the
drug development pipeline as represented on
clinicaltrials.gov.MethodsClinicaltrials.gov was assessed as of January 30, 2018
to determine AD therapies represented in...
Alzheimer's disease drug development pipeline: 2017
Tập 3 Số 3 - Trang 367-384 - 2017
AbstractIntroductionThere is an urgent need to develop new treatments for
Alzheimer's disease (AD) and to understand the drug development process for new
AD therapies.MethodsWe assessed the agents in the AD pipeline as documented in
clinicaltrials.gov for phase I, phase II, and phase III, accessed
1/5/2017.ResultsThere are 105 agents in the AD treatment development pipeline,
of which 25 agents are...
Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health
Tập 3 Số 3 - Trang 291-300 - 2017
AbstractCognitive decline leading to dementia represents a global health burden.
In the absence of targeted pharmacotherapy, lifestyle approaches remain the best
option for slowing the onset of dementia. However, older adults spend very
little time doing moderate to vigorous exercise and spend a majority of time in
sedentary behavior. Sedentary behavior has been linked to poor glycemic control
and...
Amyloid‐associated increases in longitudinal report of subjective cognitive complaints
Tập 4 - Trang 444-449 - 2018
AbstractIntroductionTo investigate whether baseline subjective cognitive
complaints (SCCs) predict longitudinal decline on neuropsychological testing and
whether SCC increases longitudinally, in the setting of high levels of amyloid
burden.MethodsTwo hundred seventy‐nine clinically normal older participants
(mean age = 73.7 ± 6.1 years) from the Harvard Aging Brain Study, a cohort of
community‐dwe...
Accelerating drug development for Alzheimer's disease through the use of data standards
Tập 3 - Trang 273-283 - 2017
AbstractIntroductionThe exceedingly high rate of failed trials in Alzheimer's
disease (AD) calls for immediate attention to improve efficiencies and learning
from past, ongoing, and future trials. Accurate, highly rigorous standardized
data are at the core of meaningful scientific research. Data standards allow for
proper integration of clinical data sets and represent the essential foundation
for...
Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
Tập 4 - Trang 37-45 - 2018
AbstractIntroductionTranslational inhibition of amyloid precursor protein (APP)
by Posiphen has been shown to reduce APP and its fragments in cell culture,
animal models, and mildly cognitively impaired patients, making it a promising
drug candidate for the treatment of Alzheimer's disease.MethodsWe used a mouse
model of Alzheimer's disease (APP/presenilin‐1) to examine Posiphen's efficacy,
pharma...
Using data science to diagnose and characterize heterogeneity of Alzheimer's disease
Tập 5 - Trang 264-271 - 2019
AbstractIntroductionDespite the availability of age‐ and education‐adjusted
standardized scores for most neuropsychological tests, there is a lack of
objective rules in how to interpret multiple concurrent neuropsychological test
scores that characterize the heterogeneity of Alzheimer's disease.MethodsUsing
neuropsychological test scores of 2091 participants from the Framingham Heart
Study, we dev...
Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficits
Tập 4 - Trang 89-102 - 2018
AbstractIntroductionPhospholipase D (PLD), a lipolytic enzyme that breaks down
membrane phospholipids, is also involved in signaling mechanisms downstream of
seven transmembrane receptors. Abnormally elevated levels of PLD activity are
well‐established in Alzheimer's disease (AD), implicating the two isoforms of
mammalian phosphatidylcholine cleaving PLD (PC‐PLD1 and PC‐PLD2). Therefore, we
took a...
Estrogen activates Alzheimer's disease genes
Tập 5 - Trang 906-917 - 2019
AbstractIntroductionWomen are at increased risk for Alzheimer's disease (AD),
but the reason why remains unknown. One hypothesis is that low estrogen levels
at menopause increases vulnerability to AD, but this remains unproven.MethodsWe
compared neuronal genes upregulated by estrogen in ovariectomized female rhesus
macaques with a database of >17,000 diverse gene sets and applied a rare variant
bu...